CYTEK-Cytek Biosciences, Inc. (CTKB) Reports Q2 Loss, Lags Revenue Estimates

Cytek Biosciences, Inc. (CTKB) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of$ 0.03. This compares to earnings of $0.01 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -166.67%. A quarter ago, it was expected that this company would post a loss of$ 0.05 per share when it actually produced a loss of $0.05, delivering no surprise. Over the last four quarters, the company has s ...